乙型肝炎病毒相关性肝细胞癌的临床特征。
Clinical features of hepatitis B virus-related hepatocellular carcinoma.
机构信息
Department of Gastroenterology and Hepatology, Saiseikai Niigata Second Hospital, Teraji 280-7, Niigata 950-1104, Japan.
出版信息
World J Gastroenterol. 2010 May 28;16(20):2463-7. doi: 10.3748/wjg.v16.i20.2463.
Abstract
Hepatocellular carcinoma (HCC) is a major cause of cancer death, and chronic hepatitis B is a serious worldwide problem. The epidemiology of HCC is distinctive. Hepatitis B virus (HBV) plays a major role in hepatocarcinogenesis. Prevention of HBV-related HCC is a key issue in current hepatology. This paper describes the prevention and clinical features of HBV-related HCC, along with a short review of the disease.
摘要
肝细胞癌（HCC）是癌症死亡的主要原因，而慢性乙型肝炎是一个全球性的严重问题。HCC 的流行病学特征独具特点。乙型肝炎病毒（HBV）在肝癌发生中起主要作用。预防 HBV 相关 HCC 是当前肝病学的一个关键问题。本文描述了 HBV 相关 HCC 的预防和临床特征，并对该疾病进行了简要回顾。
相似文献
1
Clinical features of hepatitis B virus-related hepatocellular carcinoma.
World J Gastroenterol. 2010 May 28;16(20):2463-7. doi: 10.3748/wjg.v16.i20.2463.
2
Prevention and surveillance of hepatitis B virus-related hepatocellular carcinoma.
Semin Liver Dis. 2005;25 Suppl 1:40-7. doi: 10.1055/s-2005-915649.
3
Hepatitis B viral load affects prognosis of hepatocellular carcinoma.
World J Gastroenterol. 2014 Sep 14;20(34):12039-44. doi: 10.3748/wjg.v20.i34.12039.
4
The direct and indirect roles of HBV in liver cancer: prospective markers for HCC screening and potential therapeutic targets.
J Pathol. 2015 Jan;235(2):355-67. doi: 10.1002/path.4434.
5
Perioperative antiviral therapy for chronic hepatitis B-related hepatocellular carcinoma.
Hepatobiliary Pancreat Dis Int. 2013 Jun;12(3):251-5. doi: 10.1016/s1499-3872(13)60041-7.
6
Factors predicting occurrence and prognosis of hepatitis-B-virus-related hepatocellular carcinoma.
World J Gastroenterol. 2011 Oct 14;17(38):4258-70. doi: 10.3748/wjg.v17.i38.4258.
7
Impact of antiviral therapy on post-hepatectomy outcome for hepatitis B-related hepatocellular carcinoma.
World J Gastroenterol. 2014 May 28;20(20):6006-12. doi: 10.3748/wjg.v20.i20.6006.
8
Anti-viral therapy to reduce recurrence and improve survival in hepatitis B virus-related hepatocellular carcinoma.
World J Gastroenterol. 2013 Dec 21;19(47):8861-6. doi: 10.3748/wjg.v19.i47.8861.
9
Prevention of hepatocellular carcinoma in hepatitis B virus infection.
J Gastroenterol Hepatol. 2009 Aug;24(8):1352-7. doi: 10.1111/j.1440-1746.2009.05985.x.
10
Hepatitis B Virus Pre-S Mutants as Biomarkers and Targets for the Development and Recurrence of Hepatocellular Carcinoma.
Viruses. 2020 Aug 26;12(9):945. doi: 10.3390/v12090945.
引用本文的文献
1
The role of the hepatitis B virus genome and its integration in the hepatocellular carcinoma.
Front Microbiol. 2024 Sep 6;15:1469016. doi: 10.3389/fmicb.2024.1469016. eCollection 2024.
2
Outcomes of adolescent and young patients with hepatocellular carcinoma after curative liver resection: a retrospective study.
World J Surg Oncol. 2022 Jun 21;20(1):210. doi: 10.1186/s12957-022-02658-3.
3
HBV genome-enriched single cell sequencing revealed heterogeneity in HBV-driven hepatocellular carcinoma (HCC).
BMC Med Genomics. 2022 Jun 16;15(1):134. doi: 10.1186/s12920-022-01264-2.
4
Long-term oncological prognosis after curative-intent liver resection for hepatocellular carcinoma in the young versus the elderly: multicentre propensity score-matching study.
BJS Open. 2022 Jan 6;6(1). doi: 10.1093/bjsopen/zrab145.
5
Long-read sequencing reveals the structural complexity of genomic integration of HBV DNA in hepatocellular carcinoma.
NPJ Genom Med. 2021 Oct 12;6(1):84. doi: 10.1038/s41525-021-00245-1.
6
Adenovirus Vectors Expressing Eight Multiplex Guide RNAs of CRISPR/Cas9 Efficiently Disrupted Diverse Hepatitis B Virus Gene Derived from Heterogeneous Patient.
Int J Mol Sci. 2021 Sep 29;22(19):10570. doi: 10.3390/ijms221910570.
7
C-terminal truncated HBx initiates hepatocarcinogenesis by downregulating TXNIP and reprogramming glucose metabolism.
Oncogene. 2021 Feb;40(6):1147-1161. doi: 10.1038/s41388-020-01593-5. Epub 2020 Dec 15.
8
Prognosis Factors of Young Patients Undergoing Curative Resection for Hepatitis B Virus-Related Hepatocellular Carcinoma: A Multicenter Study.
Cancer Manag Res. 2020 Jul 30;12:6597-6606. doi: 10.2147/CMAR.S261368. eCollection 2020.
9
Studies on the correlation between mutation and integration of HBV in hepatocellular carcinoma.
Biosci Rep. 2020 Aug 28;40(8). doi: 10.1042/BSR20201988.
10
Multiple novel hepatocellular carcinoma signature genes are commonly controlled by the master pluripotency factor OCT4.
Cell Oncol (Dordr). 2020 Apr;43(2):279-295. doi: 10.1007/s13402-019-00487-3. Epub 2019 Dec 17.
本文引用的文献
1
Secondary prevention of recurrence by interferon therapy after ablation therapy for hepatocellular carcinoma in chronic hepatitis C patients.
World J Gastroenterol. 2008 Oct 28;14(40):6140-4. doi: 10.3748/wjg.14.6140.
2
Efficacy of antiviral therapy with lamivudine after initial treatment for hepatitis B virus-related hepatocellular carcinoma.
J Gastroenterol Hepatol. 2007 Nov;22(11):1929-35. doi: 10.1111/j.1440-1746.2006.04707.x.
3
Improved survival for hepatocellular carcinoma with portal vein tumor thrombosis treated by intra-arterial chemotherapy combining etoposide, carboplatin, epirubicin and pharmacokinetic modulating chemotherapy by 5-FU and enteric-coated tegafur/uracil: a pilot study.
World J Gastroenterol. 2007 Nov 7;13(41):5465-70. doi: 10.3748/wjg.v13.i41.5465.
4
5
Effects of lamivudine on outcome after liver resection for hepatocellular carcinoma in patients with active replication of hepatitis B virus.
Hepatol Res. 2007 Feb;37(2):94-100. doi: 10.1111/j.1872-034X.2007.00013.x.
6
Interferon lowers tumor recurrence rate after surgical resection or ablation of hepatocellular carcinoma: a pilot study of patients with hepatitis B virus-related cirrhosis.
J Gastroenterol. 2006 Dec;41(12):1206-13. doi: 10.1007/s00535-006-1912-0. Epub 2007 Feb 6.
7
Clinicopathological differences between hepatitis B viral genotype B- and C-related resectable hepatocellular carcinoma.
J Viral Hepat. 2007 Jan;14(1):64-9. doi: 10.1111/j.1365-2893.2006.00776.x.
8
Postoperative interferon alpha treatment postponed recurrence and improved overall survival in patients after curative resection of HBV-related hepatocellular carcinoma: a randomized clinical trial.
J Cancer Res Clin Oncol. 2006 Jul;132(7):458-65. doi: 10.1007/s00432-006-0091-y. Epub 2006 Mar 24.
9
Efficacy of lamivudine for preventing hepatocellular carcinoma in chronic hepatitis B: A multicenter retrospective study of 2795 patients.
Hepatol Res. 2005 Jul;32(3):173-84. doi: 10.1016/j.hepres.2005.02.006. Epub 2005 Jul 18.
10
Differences of hepatocellular carcinoma patients with hepatitis B virus genotypes of Ba, Bj or C in Japan.
Intervirology. 2005;48(4):239-45. doi: 10.1159/000084601.
Zotero 插件